ReviewCureus2026
From the G-spot to the H-zone (Haddad Zone): Exploring an Anatomical, Neurovascular, and Regenerative Framework for Female Sexual Function.
Review in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The anatomical existence of the Gräfenberg Spot (G-spot) remains unverified, and emerging neurovascular research suggests that female sexual responsiveness arises from a broader, continuous anterior vaginal region. This functional area, now defined as the Haddad Zone (H-zone), exhibits dense mechanosensory, vascular, and connective-tissue integration. Regenerative biologics such as platelet-rich plasma (PRP), autologous extracellular vesicles (EVs), mesenchymal stromal cell-derived exosomes, and plant-derived nanovesicles exhibit molecular activity associated with sexual arousal, lubrication, and mucosal health. This review aimed to explore the anterior vaginal wall as an integrated anatomical and neurovascular region and to propose a conceptual framework for understanding regenerative biologic therapies targeting the H-zone. This narrative review and conceptual framework article synthesizes published evidence on female sexual anatomy, anterior vaginal wall neurovascular physiology, the historical G-spot concept, and emerging regenerative biologic therapies. Relevant literature on platelet-rich plasma, extracellular vesicles, mesenchymal stromal cell-derived exosomes, hyaluronic acid-based interventions, vaginal tissue biology, and sexual-function outcomes was reviewed to develop a hypothesis-generating model of the H-zone. The procedural discussion is presented as an anatomically informed conceptual rationale and should not be interpreted as prospective procedural validation. No original randomized clinical trial, laboratory analysis, procedural validation study, or human-subject intervention was conducted. The reviewed literature suggests that the anterior vaginal wall may function as a continuous erogenous region rather than a discrete focal structure. Regenerative biologics appear to influence pathways such as vascular endothelial growth factor (VEGF), Phosphoinositide 3-kinase/Protein Kinase B (PI3K/Akt), extracellular signal-regulated kinase (ERK), transforming growth factor-beta 1 (TGF-β), and hypoxia-inducible factor-1 alpha (HIF-1α), which are relevant to angiogenesis, epithelial restoration, extracellular matrix remodeling, neurosensory responsiveness, and lubrication. In contrast, mechanical augmentation, such as focal hyaluronic acid bulking, primarily provides tissue projection and does not directly address these biological pathways. The H-zone offers a biologically plausible anatomical and neurovascular framework for understanding female sexual function beyond the traditional focal G-spot concept. Regenerative biologic therapies may influence pathways relevant to vascularity, epithelial integrity, extracellular matrix remodeling, lubrication, and neurosensory responsiveness; however, current evidence remains preliminary and largely indirect. Further controlled clinical and translational studies are required before whole-zone regenerative therapy can be considered an established or superior treatment approach.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.